20 Best Healthcare Dividend Stocks With Yields Up To 6.08%

The health care sector includes a wide variety of companies operating in various industries, such as biotechnology, long-term care facilities, drug manufacturing, medical devices and equipment industries.

Due to an aging population in the United States, the availability of a wide spectrum of medical services to prolong life and increasing demand from baby boomers for medical services, the health care sector is poised to continue growing at an above-average rate compared to broad U.S. market returns.

From 2010 to 2015, various industries within the health care sector have generated average annual returns ranging between 17% for long-term care facilities to 34% for biotechnology companies, which is substantially above the average market return in the U.S.

Overall, the health care sector is poised to continue growing and generating excess returns due to ongoing innovation and strong patent protection. Also, due to stable cash flows and a solid pipeline of products, most health care companies can afford to pay out substantial amounts of their earnings to their shareholders, resulting in high dividend yields that average from 3 to 4% as of September 2015.

Looking for high-yielding dividend stocks from the healthcare sector? We've listed the top yielders without any restrictions. Here they are...

10 Highest Yielding Healthcare Dividend Stocks

Healthcare's stable revenue and growing demand due to aging baby boomers makes it a hit with income investors, but not every healthcare stock with a big dividend yield is ripe to buy. 

These 10 healthcare stocks offer the best dividend yields in the sector, yet investors should avoid most of them. 

The 10 best dividend yields in healthcare We'll get into the nitty-gritty of which of these stocks are buys and sells in a minute, but first let's take a look at the list of the top 10 highest-dividend-yielding healthcare stocks:

12 Stocks With A Fantastic Dividend History But Partly Flat Dividends (Part II)

A growing dividend is the basis for future wealth if they will be paid regular and grown over years.

Dividend growth investors focus on this issue and have strong efforts when selecting a stock.

Recently, I wrote about stocks with a wonderful dividend history but they are not part of the Dividend Champions League due to the fact that they have run its dividends flat for a while.

In my view, it's not a reason why you should not own the company. I've selected a few great names and hope you can find some inpirational ideas.

These are the results....

13 Highly Shorted Healthcare Dividend Stocks

Healthcare dividend stocks with the highest float short ratio originally published at "long-term-investments.blogspot.com". Selling a stock short is a popular method by investors to make a capital gain in a falling market. If investors believe that the stock price should fall, they borrow shares of the company and sell them on the market in order to hope that the stock price falls much more and that he can buy back the borrowed shares for a cheaper price.

Activists often sell stocks short. They try to scary other investors. Today I like to show you which of the healthcare stocks have the highest float short ratio. The ratio shows you how many shares have been sold short. It’s ever interesting to see which companies have some problems and investors like to speculate on a falling stock price. The higher the ratio is, the bigger the problems of the company.

These are my criteria:

- Positive Dividend Yield

- Healthcare Sector Relationship

- Float Short Ratio over 5 percent

Thirteen healthcare dividend stocks have fulfilled these criteria. Eight of them have a current buy or better rating.

20 Of The Best Yielding Healthcare Growth Stocks For The Next Years

Healthcare dividend stocks with best yields and big growth perspectives originally published at "long-term-investments.blogspot.com". 

The healthcare sector is one of my favorite sectors behind the consumer goods sector. I love stocks from the medical equipment and appliances industry. Sure they offer a lower dividend but most of the stocks are major diversified in terms of international sales and they have a wonderful growth perspective.

Stocks from the whole healthcare sector have a total market capitalization of USD 66.298 billion. The average stock from the sector has a P/E of 26.63 and yield at 3.32 percent. These are very attractive figures from the earnings perspective. Debt is also high with a long-term debt to equity ratio of 88.63. As a result, the return on equity amounts to 17.61 percent.

Today I like to show you the best yielding healthcare growth opportunities at the market. I screened all healthcare stocks with a positive dividend payment and double-digit earnings per share growth for the next five years.

Nearly 40 companies fulfilled these criteria but some of them pay only very low dividends. Below is a small list of 20 stocks with the highest yield. Eleven of the results have a buy or better rating.

16 Best Dividend Paying Healthcare Stocks

Best Dividend Paying Healthcare Stocks Researched By “long-term-investments.blogspot.com”. The healthcare sector is a great investment field with fantastic growth potential. The whole sector has a total market capitalization of USD 43.18 trillion and summarizes 543 companies. The average dividend yield amounts to 3.34 percent and the P/E ratio is 22.59.

In order to find the best dividend paying stocks within the sector, I screened all companies with a positive dividend yield, great earnings per share growth of more than five percent and an operating margin over 15 percent. In order get the best results in terms of low debt and high cash, the debt to equity ratio should be under 0.5. Sixteen healthcare companies remain of which four yielding over three percent and thirteen are currently recommended to buy.

15 Of The Best Growing Dividend Achievers

Best Growing Dividend Achievers Researched By Dividend Yield - Stock, Capital, Investment. Dividend Achievers are stocks with consecutive dividend hikes of more than 10 years. At the moment are 186 companies available which have fulfilled these dividend growth criteria. Growth is a wealth driver. Let’s identify the best growing Dividend Achievers.

I screened the investment category by the stocks with the highest expected growth, measured by an average five year earnings per share growth of at least 15 percent. Exactly 15 stocks remained of which nine are currently recommended to buy.

12 Healthcare Dividend Stocks With Highest Short Float Ratio

Healthcare Dividend Stocks With Highest Short Float Ratio Researched By Dividend Yield - Stock, Capital, Investment. The healthcare sector is a major business. At the stock markets are 551 companies linked to the sector with a total market capitalization of USD 40.4 trillion. The average sector yield amounts to 3.93 percent and the average P/E ratio is 22.31.

I screened the sector by dividend stocks with the highest amount of short selling stocks, measured by the short float ratio. The ratio shows how many stocks are shorted by investors. Companies with a high ratio of short float have a little upside potential if investors need to close their short position. Twelve dividend stocks from the healthcare sector have a short float ratio of more than 5 percent and six are recommended to buy.

The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth

Healthcare Stocks With The Best Dividend Yield And Fastest Earnings Per Share Growth, Researched by Dividend Yield - Stock, Capital, Investment. Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings per share growth for the upcoming five years (at least 5 percent yearly). In addition, the company should pay today more than three percent in dividends. 10 stocks fulfilled my criteria of which six yielding above 4 percent. Nine stocks have a buy recommendation and one a strong buy rating.

5 Interesting Latin High Yields To Consider

Five NYSE-Listed Latin American Stocks Yielding More Than 5% Dividends By Topforeignstocks. Some investors have the misconception that one should invest in emerging stocks mainly for capital appreciation. However that need not be the case. Many emerging market stocks pay above average dividends and hence they are attractive for both capital growth and dividend income. Below are five Latin American ADRs with a yield of more than 5 percent.

1. Company: Administradora de Fondos de Pensiones Provida SA (PVD)
Current Dividend Yield: 9.64%
Sector: Investment Services
Country: Chile

2. Company: Cpfl Energia SA (CPL)
Current Dividend Yield: 5.25%
Sector: Electric Utilities
Country: Brazil

3. Company: YPF Sociedad Anonima (YPF)
Current Dividend Yield: 9.15%
Sector: Integrated Oil & Gas
Country: Argentina

4. Company: Telefonos de Mexico SAB de CV (TMX)
Current Dividend Yield: 5.62%
Sector: Telecom
Country: Mexico

5. Company: Telefonica Brasil SA (VIV)
Current Dividend Yield: 13.33%
Sector: Telecom
Country: Brazil

Source: Topforeignstocks.com

15 Healthcare Dividend Stocks With Buy Or Better Recommendation

Healthcare Dividend Shares With Buy And Stong Buy Rating researched by Dividend Yield - Stock, Capital, Investment. Here is a current overview of stocks from the healthcare sector with a minimum dividend yield of 3 percent that have an actual buy or better rating outstanding. The recommendations are made by analysts and brokerage firms and measured on a scale between one and five. I listed all healthcare dividend stocks with a rating above 3 (buy or better). Exactly 15 companies fulfilled these criteria of which 8 have a strong buy rating and 7 a buy recommendation.

Here are the 3 top dividend stocks sorted by yield:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

Psychemedics (NASDAQ: PMD) has a market capitalization of $47.64 million. The company employs 91 people, generates revenues of $20.11 million and has a net income of $2.61 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4.70 million. Because of these figures, the EBITDA margin is 23.36 percent (operating margin 21.95 percent and the net profit margin finally 13.00 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 27.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.66. Last fiscal year, the company paid $0.48 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 13.76, Price/Sales 2.37 and Price/Book ratio 4.87. Dividend Yield: 5.27 percent. The beta ratio is 0.84.

Long-Term Stock History Chart Of Psychemedics Corp. (Click to enlarge)

Long-Term History of Dividends from Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge)

Long-Term Dividend Yield History of Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge)

GlaxoSmithKline (NYSE: GSK) has a market capitalization of $115.53 billion. The company employs 96,461 people, generates revenues of $44,106.82 million and has a net income of $2,878.62 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,494.51 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).


The total debt representing 35.76 percent of the company’s assets and the total debt in relation to the equity amounts to 169.91 percent. Due to the financial situation, a return on equity of 17.30 percent was realized. Twelve trailing months earnings per share reached a value of $2.02. Last fiscal year, the company paid $2.02 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 22.61, Price/Sales 2.60 and Price/Book ratio 8.41. Dividend Yield: 4.83 percent. The beta ratio is 0.63.

Long-Term Stock History Chart Of GlaxoSmithKline plc (ADR) (Click to enlarge)

Long-Term History of Dividends from GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge)

Long-Term Dividend Yield History of GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge)

Sanofi SA (NYSE: SNY) has a market capitalization of $98.09 billion. The company employs 101,575 people, generates revenues of $41,469.25 million and has a net income of $5,640.13 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,867.96 million. Because of these figures, the EBITDA margin is 33.44 percent (operating margin 18.59 percent and the net profit margin finally 13.60 percent).


The total debt representing 9.69 percent of the company’s assets and the total debt in relation to the equity amounts to 15.56 percent. Due to the financial situation, a return on equity of 10.78 percent was realized. Twelve trailing months earnings per share reached a value of $2.29. Last fiscal year, the company paid $1.62 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 15.93, Price/Sales 2.38 and Price/Book ratio 1.39. Dividend Yield: 4.83 percent. The beta ratio is 0.89.

Long-Term Stock History Chart Of Sanofi SA (ADR) (Click to enlarge)

Long-Term History of Dividends from Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge)

Long-Term Dividend Yield History of Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

15 Healthcare Dividend Stocks With Buy Or Better Recommendation (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.45 while the forward price to earnings ratio is 12.11. The dividend yield has a value of 3.99 percent. Price to book ratio is 3.11 and price to sales ratio 2.28. The operating margin amounts to 18.50 percent.

Related stock ticker symbols:

PMD, SNY, GSK, NDZ, MRK, NVS, PFE, VIVO, AVCA, BMY, UTMD, JNJ, ABT, MSA, LNCR

Selected Articles:

· Best Healthcare Stock Picks For 2012

· 10 High Yielding Drug Manufacturers

· 12 Best Yielding Medical Instruments And Supplies Stocks

· Best Pharmaceutical Shares For Income Investors

I am long JNJ. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.

For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

10 High Margin Healthcare Dividend Shares

Perfect Healthcare Dividend Stocks With High Margins by Dividend Yield - Stock, Capital, Investment. I screened stocks from the healthcare sector with a positive dividend yield as well as an operating margin of more than 25 percent. Most of the stocks come from the medical instruments and supplies industry but the highest margin stocks are from the drug, biotechnology and diagnostic industry. 5 stocks from the screening results have a yield of more than 3 percent.

Here are the 3 top dividend stocks sorted by yield:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

PDL BioPharma (NASDAQ: PDLI) has a market capitalization of $866.97 million. The company employs 8 people, generates revenues of $344.98 million and has a net income of $91.87 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $193.52 million. Because of these figures, the EBITDA margin is 56.10 percent (operating margin 56.07 percent and the net profit margin finally 26.63 percent).


The total debt representing 178.77 percent of the company’s assets. Twelve trailing months earnings per share reached a value of $0.74. Last fiscal year, the company paid $1.00 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 8.43, Price/Sales 2.51 and Price/Book ratio is not calculable. Dividend Yield: 9.68 percent. The beta ratio is 0.54.

Long-Term Stock History Chart Of PDL BioPharma Inc. (Click to enlarge)

Long-Term History of Dividends from PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

Long-Term Dividend Yield History of PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

AstraZeneca (NYSE: AZN) has a market capitalization of $61.13 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55 percent and the net profit margin finally 24.29 percent).


The total debt representing 16.43 percent of the company’s assets and the total debt in relation to the equity amounts to 39.73 percent. Due to the financial situation, a return on equity of 36.71 percent was realized. Twelve trailing months earnings per share reached a value of $7.29. Last fiscal year, the company paid $2.55 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 6.35, Price/Sales 1.78 and Price/Book ratio 2.81. Dividend Yield: 5.83 percent. The beta ratio is 0.62.

Long-Term Stock History Chart Of AstraZeneca plc (ADR) (Click to enlarge)

Long-Term History of Dividends from AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Long-Term Dividend Yield History of AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Meridian Bioscience (NASDAQ: VIVO) has a market capitalization of $777.02 million. The company employs 525 people, generates revenues of $159.72 million and has a net income of $26.83 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $45.73 million. Because of these figures, the EBITDA margin is 28.63 percent (operating margin 25.06 percent and the net profit margin finally 16.80 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 19.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.65. Last fiscal year, the company paid $0.76 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 29.03, Price/Sales 4.86 and Price/Book ratio 5.61. Dividend Yield: 4.03 percent. The beta ratio is 0.80.

Long-Term Stock History Chart Of Meridian Bioscience, Inc. (Click to enlarge)

Long-Term History of Dividends from Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Long-Term Dividend Yield History of Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

10 High Margin Healthcare Dividend Shares (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.62 while the forward price to earnings ratio is 14.23. The dividend yield has a value of 3.46 percent. Price to book ratio is 4.28 and price to sales ratio 4.17. The operating margin amounts to 37.47 percent.

Related stock ticker symbols:

PDLI, AZN, VIVO, BMY, UTMD, AMGN, TECH, NVO, MLAB, ATRI

Selected Articles:

· Best Healthcare Stock Picks For 2012

· 12 Healthcare Dividend Stocks With Best Future EPS Growth

· 14 Healthcare Dividend Stocks With Biggest Institutional Buys

· 8 Healthcare Dividend Stocks Close to 52-Week Low

* I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.